Literature DB >> 2327473

Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence.

D X Divaris1, J C Kennedy, R H Pottier.   

Abstract

The skin of albino mice given 5-aminolevulinic acid (ALA) by intraperitoneal injection rapidly developed the characteristic red fluorescence of protoporphyrin IX. Fluorescence microscopy of frozen tissue sections revealed intense red fluorescence within the sebaceous glands and a much weaker fluorescence within the epidermis and hair follicles. Little or no fluorescence was detected in the dermis, blood vessels, or cartilage of the ear. Light microscopy of skin taken at intervals after whole-body exposure of ALA-injected mice to photoactivating light revealed destruction of sebaceous cells, focal epidermal necrosis with a transient acute inflammation, and diffuse reactive changes in the keratinocytes. The dermis showed transient secondary edema and inflammation. The location and severity of the phototoxic damage correlated well with the location and intensity of the red fluorescence. The light-exposed skin appeared to recover completely except for a persistent reduction in the number of hair follicles.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2327473      PMCID: PMC1877631     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  11 in total

1.  The metabolism of delta -aminolaevulic acid. 2. Normal pathways, studied with the aid of 14C.

Authors:  N I BERLIN; A NEUBERGER; J J SCOTT
Journal:  Biochem J       Date:  1956-09       Impact factor: 3.857

Review 2.  Photodynamic therapy.

Authors:  M J Manyak; A Russo; P D Smith; E Glatstein
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

3.  Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain.

Authors:  P J Muller; B C Wilson
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

4.  Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo.

Authors:  R H Pottier; Y F Chow; J P LaPlante; T G Truscott; J C Kennedy; L A Beiner
Journal:  Photochem Photobiol       Date:  1986-11       Impact factor: 3.421

5.  A rapid method for the differentiation of Haemophilus strains. The porphyrin test;.

Authors:  M Kilian
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-12

6.  The nature of the chromophore responsible for naturally occurring fluorescence in mouse skin.

Authors:  G Weagle; P E Paterson; J Kennedy; R Pottier
Journal:  J Photochem Photobiol B       Date:  1988-11       Impact factor: 6.252

7.  Ratioing fluorometer probe for localizing carcinoma in situ in bronchi of the lung.

Authors:  O J Balchum; A E Profio; N Razum
Journal:  Photochem Photobiol       Date:  1987-11       Impact factor: 3.421

8.  The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N.

Authors:  N I BERLIN; A NEUBERGER; J J SCOTT
Journal:  Biochem J       Date:  1956-09       Impact factor: 3.857

9.  Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder.

Authors:  G R Prout; C W Lin; R Benson; U O Nseyo; J J Daly; P P Griffin; J Kinsey; M E Tian; Y H Lao; Y Z Mian
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

10.  Experimental porphyric neuropathy: a preliminary report.

Authors:  A A Sima; J C Kennedy; D Blakeslee; D M Robertson
Journal:  Can J Neurol Sci       Date:  1981-05       Impact factor: 2.104

View more
  34 in total

1.  Clinical Efficacy of Self-applied Blue Light Therapy for Mild-to-Moderate Facial Acne.

Authors:  Michael H Gold; Anneke Andriessen; Julie Biron; Hinke Andriessen
Journal:  J Clin Aesthet Dermatol       Date:  2009-03

2.  Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.

Authors:  R Bachor; E Reich; A Rück; R Hautmann
Journal:  Urol Res       Date:  1996

Review 3.  Laser treatments of active acne.

Authors:  Lauren E Wiznia; Mary L Stevenson; Arielle R Nagler
Journal:  Lasers Med Sci       Date:  2017-08-04       Impact factor: 3.161

Review 4.  Photodynamic Therapy and Skin Appendage Disorders: A Review.

Authors:  Matteo Megna; Gabriella Fabbrocini; Claudio Marasca; Giuseppe Monfrecola
Journal:  Skin Appendage Disord       Date:  2016-12-08

5.  Topical ALA-Photodynamic Therapy for Acne Can Induce Apoptosis of Sebocytes and Down-regulate Their TLR-2 and TLR-4 Expression.

Authors:  Eugene Jeong; Ji Won Hong; Jung Ah Min; Dong Won Lee; Mi Yeung Sohn; Weon Ju Lee; Jun Young Lee; Young Min Park
Journal:  Ann Dermatol       Date:  2011-02-28       Impact factor: 1.444

Review 6.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

7.  Topical drug delivery in humans with a single photomechanical wave.

Authors:  S Lee; N Kollias; D J McAuliffe; T J Flotte; A G Doukas
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

8.  The effect of multiple sequential light sources to activate aminolevulinic Acid in the treatment of actinic keratoses: a retrospective study.

Authors:  Daniel P Friedmann; Mitchel P Goldman; Sabrina G Fabi; Isabella Guiha
Journal:  J Clin Aesthet Dermatol       Date:  2014-09

9.  Intermolecular Structural Change for Thermoswitchable Polymeric Photosensitizer.

Authors:  Wooram Park; Sin-Jung Park; Soojeong Cho; Heejun Shin; Young-Seok Jung; Byeongdu Lee; Kun Na; Dong-Hyun Kim
Journal:  J Am Chem Soc       Date:  2016-08-23       Impact factor: 15.419

10.  Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins.

Authors:  K Orth; K König; F Genze; A Rück
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.